☰

Benjamin J. Wilkins, Ph.D. - Publications

Affiliations: 
2004 University of Cincinnati, Cincinnati, OH 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Chatterji P, Williams PA, Whelan KA, Samper FC, Andres SF, Simon LA, Parham LR, Mizuno R, Lundsmith ET, Lee DS, Liang S, Wijeratne HS, Marti S, Chau L, Giroux V, ... Wilkins BJ, et al. Posttranscriptional regulation of colonic epithelial repair by RNA binding protein IMP1/IGF2BP1. Embo Reports. PMID 31061170 DOI: 10.15252/Embr.201847074  0.353
2018 Hu P, Liu J, Zhao J, Wilkins BJ, Lupino K, Wu H, Pei L. Single-nucleus transcriptomic survey of cell diversity and functional maturation in postnatal mammalian hearts. Genes & Development. PMID 30254108 DOI: 10.1101/Gad.316802.118  0.34
2018 Terry NA, Ngaba LV, Wilkins BJ, Pi D, Gheewala N, Kaestner KH. Lipid Malabsorption from Altered Hormonal Signaling Changes Early Gut Microbial Responses. American Journal of Physiology. Gastrointestinal and Liver Physiology. PMID 29953253 DOI: 10.1152/Ajpgi.00135.2018  0.315
2017 Wang T, Liu J, McDonald C, Lupino K, Zhai X, Wilkins BJ, Hakonarson H, Pei L. GDF15 is a heart-derived hormone that regulates body growth. Embo Molecular Medicine. PMID 28572090 DOI: 10.15252/Emmm.201707604  0.37
2007 Purcell NH, Wilkins BJ, York A, Saba-El-Leil MK, Meloche S, Robbins J, Molkentin JD. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proceedings of the National Academy of Sciences of the United States of America. 104: 14074-9. PMID 17709754 DOI: 10.1073/Pnas.0610906104  0.676
2006 Liu Q, Wilkins BJ, Lee YJ, Ichijo H, Molkentin JD. Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth. Molecular and Cellular Biology. 26: 3785-97. PMID 16648474 DOI: 10.1128/Mcb.26.10.3785-3797.2006  0.6
2005 Sanna B, Bueno OF, Dai YS, Wilkins BJ, Molkentin JD. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth. Molecular and Cellular Biology. 25: 865-78. PMID 15657416 DOI: 10.1128/Mcb.25.3.865-878.2005  0.684
2004 Wilkins BJ, Molkentin JD. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochemical and Biophysical Research Communications. 322: 1178-91. PMID 15336966 DOI: 10.1016/J.Bbrc.2004.07.121  0.643
2004 Lips DJ, Bueno OF, Wilkins BJ, Purcell NH, Kaiser RA, Lorenz JN, Voisin L, Saba-El-Leil MK, Meloche S, Pouysségur J, Pagès G, De Windt LJ, Doevendans PA, Molkentin JD. MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation. 109: 1938-41. PMID 15096454 DOI: 10.1161/01.Cir.0000127126.73759.23  0.619
2004 Parsons SA, Millay DP, Wilkins BJ, Bueno OF, Tsika GL, Neilson JR, Liberatore CM, Yutzey KE, Crabtree GR, Tsika RW, Molkentin JD. Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. The Journal of Biological Chemistry. 279: 26192-200. PMID 15082723 DOI: 10.1074/Jbc.M313800200  0.739
2004 Searle JS, Schollaert KL, Wilkins BJ, Sanchez Y. The DNA damage checkpoint and PKA pathways converge on APC substrates and Cdc20 to regulate mitotic progression. Nature Cell Biology. 6: 138-45. PMID 14743219 DOI: 10.1038/Ncb1092  0.327
2004 Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, Jones F, Kimball TR, Molkentin JD. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circulation Research. 94: 110-8. PMID 14656927 DOI: 10.1161/01.Res.0000109415.17511.18  0.749
2004 Bueno OF, Lips DJ, Kaiser RA, Wilkins BJ, Dai YS, Glascock BJ, Klevitsky R, Hewett TE, Kimball TR, Aronow BJ, Doevendans PA, Molkentin JD. Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction. Circulation Research. 94: 91-9. PMID 14615291 DOI: 10.1161/01.Res.0000107197.99679.77  0.633
2003 Liang Q, Bueno OF, Wilkins BJ, Kuan CY, Xia Y, Molkentin JD. c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling. The Embo Journal. 22: 5079-89. PMID 14517246 DOI: 10.1093/Emboj/Cdg474  0.712
2003 Parsons SA, Wilkins BJ, Bueno OF, Molkentin JD. Altered skeletal muscle phenotypes in calcineurin Aalpha and Abeta gene-targeted mice. Molecular and Cellular Biology. 23: 4331-43. PMID 12773574 DOI: 10.1128/Mcb.23.12.4331-4343.2003  0.719
2003 Braz JC, Bueno OF, Liang Q, Wilkins BJ, Dai YS, Parsons S, Braunwart J, Glascock BJ, Klevitsky R, Kimball TF, Hewett TE, Molkentin JD. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. The Journal of Clinical Investigation. 111: 1475-86. PMID 12750397 DOI: 10.1172/Jci17295  0.757
2002 Wilkins BJ, De Windt LJ, Bueno OF, Braz JC, Glascock BJ, Kimball TF, Molkentin JD. Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth. Molecular and Cellular Biology. 22: 7603-13. PMID 12370307 DOI: 10.1128/Mcb.22.21.7603-7613.2002  0.711
2002 Wilkins BJ, Molkentin JD. Calcineurin and cardiac hypertrophy: where have we been? Where are we going? The Journal of Physiology. 541: 1-8. PMID 12015416 DOI: 10.1113/Jphysiol.2002.017129  0.651
2002 Bueno OF, Wilkins BJ, Tymitz KM, Glascock BJ, Kimball TF, Lorenz JN, Molkentin JD. Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 99: 4586-91. PMID 11904392 DOI: 10.1073/Pnas.072647999  0.667
2002 Braz JC, Bueno OF, Wilkins BJ, Braunwart J, Molkentin JD. 05 Inhibition of p38 mitogen-activated protein kinase (MAPK) leads to hypertrophic cardiomyopathy Journal of Molecular and Cellular Cardiology. 34: A12. DOI: 10.1016/S0022-2828(02)90111-2  0.462
2001 Wilkins BJ, DeWindt LJ, Bueno OF, Braz JC, Molkentin JD. Loss of NF-ATc3, not NF-ATc4, attenuates cardiac hypertrophy induced by calcineurin activation in vivo Journal of Molecular and Cellular Cardiology. 33: A130. DOI: 10.1016/S0022-2828(01)90519-X  0.508
2001 Bueno OF, Wilkins BJ, Klevitsky R, Hewitt TE, Molkentin JD. Impaired hypertrophic response in calcineurin Aβ-deficient mice Journal of Molecular and Cellular Cardiology. 33: A17. DOI: 10.1016/S0022-2828(01)90066-5  0.502
Show low-probability matches.